Geneva, Agencies– On Friday, the World Health Organization (WHO) approved the emergency use of the single-dose Corona vaccine by the American pharmaceutical company Johnson & Johnson. With the approval of the WHO, this vaccine can now be delivered to poor countries under the international COVAX campaign, which has not yet received a vaccine. The special feature of the Johnson & Johnson vaccine is that it requires only one dose instead of two doses. Two doses of other vaccines must be used.
In the WHO statement, insufficient data from large clinical trials have been reported on the efficacy of this vaccine for adults. The day before the approval of the United Nations Health Agency, the European Medicines Agency of the European Union of 27 countries approved the use of this vaccine.
WHO Director-General Tedros Adhom Ghebreyes said at a press conference on Friday that a new vaccine had been made available. We should ensure that it is available to people all over the world, not limited to a few countries and populations. Meanwhile, the French health regulator has also approved the use of the Johnson & Johnson vaccine. The regulator said that this vaccine could be administered to people over the age of 18 in France.
US Emergency Use Approval
Recently, the US Food and Drug Administration (FDA) also approved the emergency use of Johnson & Johnson anticoron vaccine. This is the third vaccine to be used in the United States to prevent coronary artery infection. The US government has bought 100 million doses of this vaccine. The company claims to have provided 20 million doses by the end of March. Pfizer and Mordana vaccines were approved by the US in December last year.